Zymogenetics

Develop protein therapies for hematology, cancer, and inflammatory disorders

placeNew York City, New York, United States calendar_todayFounded 1981 groups65 employees language zymogenetics.com

Innovation

292 patent families (206 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing, Electricity & electronics; filing pace slowing. Cited 49,409 times.

YearFilings
201363
201449
201528
201630
201725
201817
201913
202010
20214
20223
20231
20251

Investor mix

4 investors on record; 2 have since exited.

Investor typeCountShare
Venture capital125%
Private equity125%
Bank & private debt125%
Other / undisclosed125%
Coming soon